Thurston Springer Miller Herd & Titak’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $323K | Buy |
4,624
+22
| +0.5% | +$1.54K | 0.04% | 301 |
|
|
2025
Q1 | $338K | Buy |
4,602
+531
| +13% | +$39K | 0.06% | 237 |
|
|
2024
Q4 | $267K | Buy |
4,071
+485
| +14% | +$31.8K | 0.05% | 241 |
|
|
2024
Q3 | $279K | Buy |
3,586
+1,700
| +90% | +$132K | 0.08% | 211 |
|
|
2024
Q2 | $147K | Sell |
1,886
-6,792
| -78% | -$530K | 0.05% | 350 |
|
|
2024
Q1 | $588K | Buy |
+8,678
| New | +$588K | 0.24% | 32 |
|